China SXT Pharmaceuticals, Inc. (SXTC)
Automate Your Wheel Strategy on SXTC
With Tiblio's Option Bot, you can configure your own wheel strategy including SXTC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol SXTC
- Rev/Share 0.8018
- Book/Share 11.2946
- PB 0.1293
- Debt/Equity 0.19
- CurrentRatio 1.5989
- ROIC 0.399
- MktCap 38000588.0
- FreeCF/Share -1.0991
- PFCF -28.0333
- PE 0.2729
- Debt/Assets 0.1145
- DivYield 0
- ROE 0.4736
- Rating
- Score
- Recommendation
- P/E Score
- DCF Score
- P/B Score
- D/E Score
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
China SXT Pharmaceuticals, Inc. Announces Share Consolidation
Published: February 21, 2025 by: GlobeNewsWire
Sentiment: Neutral
TAIZHOU, China, Feb. 21, 2025 (GLOBE NEWSWIRE) -- China SXT Pharmaceutics, Inc. (Nasdaq: SXTC) (the “Company” or “SXTC”), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (“TCMPs”), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements (“TCMHS”), today announced that it will effect a share consolidation of its ordinary shares at a ratio of 1-for-8, effective on February 25, 2025 (the “Share Consolidation”). The Company's ordinary shares are expected to begin trading on a post-consolidation basis at the open of the market session …
Read More
About China SXT Pharmaceuticals, Inc. (SXTC)
- IPO Date 2019-01-04
- Website https://www.sxtchina.com
- Industry Drug Manufacturers - Specialty & Generic
- CEO Mr. Feng Zhou
- Employees 75